Adenosine Deaminase Deficiency Associated Severe Combined Immunodeficiency

• CLINICAL_TRIALS research · 2025-12-18
  Clinical Trial Update: An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID

  This clinical trial update describes an observational follow-up study of patients previously treated with autologous ex vivo gene therapy fo…

• FDA label_change · 2020-12-05
  FDA Approved: REVCOVI — Supplemental Application (Chiesi USA, Inc.)

  FDA approved a supplemental application for REVCOVI (elapegademase-lvlr) by Chiesi USA, Inc., resulting in changes to its labeling.

• FDA approval · 2018-10-05
  FDA Approved: REVCOVI — Original Application (Chiesi USA, Inc.)

  FDA approved REVCOVI (elapegademase-lvlr) from Chiesi USA as a first-in-class enzyme replacement therapy for ADA-deficiency–associated sever…